Grifols has announced positive results from its phase 2/3 clinical trial evaluating the efficacy and safety of intravenous ...

Grifols has shared positive results from its clinical trial evaluating the efficacy and safety of intravenous immunoglobulin to treat patients with PPS.

Grifols (GRFS) issued a statement to address certain information published in a media outlet on March 8, specifically a front-page article ...

Carson Block of Muddy Waters announced Grifols (GRFS) as a short idea for the Robin Hood contest, according to Bloomberg.Light Up your ...

As European markets face uncertainty due to U.S. trade policy and recent ECB rate cuts, the pan-European STOXX Europe 600 Index has snapped a 10-week streak of gains, although increased defense and ...

Grifols has filed for US approval of a new drug for rare bleeding disorder acquired fibrinogen deficiency (AFD), which promises to provide a more reliable and easier treatment for patients.

Private equity company Brookfield has reportedly moved closer to taking control of Grifols, after months of disruption at the Spanish pharma company. A report in Spanish newspaper El Confidencial ...

The global HIV diagnostics market, valued at US$2.96B in 2024, is forecasted to grow at a 10.3% CAGR, reaching US$3.25B by ...

New research reveals concerns over the Alzheimer's blood test accuracy, highlighting phosphorylated tau proteins in ALS ...

European equities traded in the US as American depositary receipts were lower late Tuesday morning, declining 1.03% to 1,388.44 on the S&P Europe Select ADR Index. From continental Europe, the gainers ...